{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:10:11Z","timestamp":1791036611033,"version":"4.1.0"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T00:00:00Z","timestamp":1176854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Photochem &amp; Photobiology"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The dried root or rhizome of <jats:italic>Goldenseal<\/jats:italic> (<jats:italic>Hydrastis canadensis<\/jats:italic> L.) contains several alkaloids including berberine, hydrastine, palmatine and lesser amounts of canadine and hydrastinine. Preparations derived from <jats:italic>Goldenseal<\/jats:italic> have been used to treat skin and eye ailments. Berberine, the major alkaloid in <jats:italic>Goldenseal<\/jats:italic> root powder, has been used in eye drops to treat trachoma, a disease characterized by keratoconjunctivitis. Berberine and palmatine are also present in extracts from <jats:italic>Berberis amurensis Ruprecht<\/jats:italic> (Berberidaceae) which are used to treat ocular disorders. We have previously shown that <jats:italic>Goldenseal<\/jats:italic> alkaloids are phototoxic to keratinocytes (<jats:italic>Chem Res Toxicol.<\/jats:italic> 14, 1529, 2001; <jats:italic>ibid<\/jats:italic> 19, 739, 2006) and now report their effect on human lens and retinal pigment epithelial cells. Human lens epithelial cells (HLE\u2010B3) were severely damaged when incubated with berberine (25\u2003\u03bc<jats:italic>M<\/jats:italic>) and exposed to UVA (5\u2003J\u2003cm<jats:sup>\u22122<\/jats:sup>). Under the same conditions, palmatine was less phototoxic and hydrastine, canadine and hydrastinine were inactive. Moderate protection against berberine phototoxicity was afforded by the antioxidants ascorbate (2\u2003m<jats:italic>M<\/jats:italic>) and <jats:italic>N<\/jats:italic>\u2010acetylcysteine (5\u2003m<jats:italic>M<\/jats:italic>). When exposed to UVA (5\u2003J\u2003cm<jats:sup>\u22122<\/jats:sup>) both berberine (10\u2003\u03bc<jats:italic>M<\/jats:italic>) and palmatine (10\u2003\u03bc<jats:italic>M<\/jats:italic>) caused mild DNA damage as determined by the alkaline comet assay which measures single strand breaks. Berberine and palmatine are the only <jats:italic>Goldenseal<\/jats:italic> alkaloids with appreciable absorption above 400\u2003nm. Because light at wavelengths below 400\u2003nm is cut off by the anterior portion of the adult human eye only berberine and palmatine were tested for phototoxicity to human retinal pigment epithelial (hRPE) cells. Although berberine did damage hRPE cells when irradiated with visible light (\u03bb\u2003&gt;\u2003400\u2003nm) approximately 10 times higher concentrations were required to produce the same amount of damage as seen in lens cells. Palmatine was not phototoxic to hRPE cells. Neither berberine nor palmatine photodamaged DNA in hRPE. Infusions of <jats:italic>Goldenseal<\/jats:italic> are estimated to contain \u223c1\u2003m<jats:italic>M<\/jats:italic> berberine, while in tinctures the alkaloid concentration may be more than 10 times higher. Our findings show that eyewashes and lotions derived from <jats:italic>Goldenseal<\/jats:italic> or containing berberine must be used with caution when the eyes are exposed to bright sunlight but that oral preparations are not likely to cause ocular phototoxicity.<\/jats:p>","DOI":"10.1111\/j.1751-1097.2007.00086.x","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T18:25:29Z","timestamp":1278440729000},"page":"938-943","source":"Crossref","is-referenced-by-count":26,"title":["Photochemistry and Photocytotoxicity of Alkaloids from <i>Goldenseal<\/i> (<i>Hydrastis canadensis<\/i> L.) 3: Effect on Human Lens and Retinal Pigment Epithelial Cells"],"prefix":"10.1111","volume":"83","author":[{"given":"Colin F.","family":"Chignell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Sik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R.","family":"Wielgus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"508","article-title":"Goldenseal","volume":"123","author":"Harmon N. W.","year":"1990","journal-title":"Canad. Pharm. J."},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf034339r"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1081\/JLC-100000329"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/jaoac\/86.3.476","article-title":"Method validation for determination of alkaloid content in goldenseal root powder","volume":"86","author":"Weber H. A.","year":"2003","journal-title":"J. AOAC Int."},{"key":"e_1_2_6_6_2","first-page":"47","article-title":"Goldenseal","volume":"41","author":"Drew A.","year":"2000","journal-title":"Curr. Ther."},{"key":"e_1_2_6_7_2","first-page":"175","article-title":"Berberine","volume":"5","author":"Anonymous","year":"2000","journal-title":"Altern. Med. Rev."},{"key":"e_1_2_6_8_2","first-page":"335","article-title":"Quality assessment of marketed Ayurvedic eye\u2010drop preparation","volume":"37","author":"Hamrapurkar P. D.","year":"2000","journal-title":"Indian Drugs"},{"key":"e_1_2_6_9_2","first-page":"83","article-title":"Effect of berberine chloride eye drops on clinically positive trachoma patients","volume":"76","author":"Babbar O. P.","year":"1982","journal-title":"Indian J. Med. Res."},{"key":"e_1_2_6_10_2","first-page":"147","article-title":"Berberine, a potential drug for trachoma","volume":"69","author":"Khosla P. K.","year":"1992","journal-title":"Rev. Int. Trach. Pathol. Ocul. Trop. Subtrop. Sante. Publique."},{"key":"e_1_2_6_11_2","first-page":"257","article-title":"Studies on the constituents of Berberis amurensis Ruprecht","volume":"28","author":"Lee H. Y.","year":"1997","journal-title":"Korean J. Pharmacognosy"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(85)90717-9"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/jf020674o"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx050356u"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx0155247"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1177\/171516350413700506"},{"key":"e_1_2_6_17_2","first-page":"22","article-title":"Epidemic dropsy: A review","volume":"3","author":"Grover J. K.","year":"1998","journal-title":"Medico-Legal Update"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1080\/10915810290169927"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/10915810290169918"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2004.06.025"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/10915810290169891"},{"key":"e_1_2_6_22_2","first-page":"2210","article-title":"Studies of human uveal melanocytes in\u00a0vitro: Isolation, purification and cultivation of human uveal melanocytes","volume":"34","author":"Hu D. N.","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_23_2","first-page":"3094","article-title":"Propagation and immortalization of human lens epithelial cells in culture","volume":"35","author":"Andley U. P.","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4827(88)90265-0"},{"key":"e_1_2_6_25_2","first-page":"471","article-title":"Superoxide dismutase isoenzymes in the human eye","volume":"39","author":"Behndig A.","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00788-8"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01797-X"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(03)00050-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.9.12.7672510"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-1425(99)00053-0"},{"key":"e_1_2_6_31_2","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1016\/S0021-9258(19)38640-5","article-title":"8\u2010Hydroxydeoxyguanosine formation at the 5\u2019 site of 5\u2019\u2010GG\u20103\u2019 sequences in double\u2010stranded DNA by UV radiation with riboflavin","volume":"268","author":"Ito K.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1021\/js9802594"},{"key":"e_1_2_6_33_2","unstructured":"Medow N. B.andJ. J.Greco(1976)Ophthamological use of hydrastis compoundsUnited States Patent. Available at:http:\/\/www.freepatentsonline.com\/3943251.html. Accessed on 20 March 2006."},{"key":"e_1_2_6_34_2","article-title":"Your Guide to Vitamins, Minerals, and Herbs","author":"Anonymous","year":"2006","journal-title":"Readers Digest"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.02.033"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300628"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0925"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000097904"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2005.09.023"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200401863"}],"container-title":["Photochemistry and Photobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-1097.2007.00086.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1751-1097.2007.00086.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T17:47:49Z","timestamp":1697046469000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1751-1097.2007.00086.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1751-1097.2007.00086.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1751-1097.2007.00086.x","archive":["Portico"],"relation":{},"ISSN":["0031-8655","1751-1097"],"issn-type":[{"value":"0031-8655","type":"print"},{"value":"1751-1097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}